HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Doxorubicin and etoposide-besed combination chemotherapy regimen for peripheral T-cell lymphoma].

AuthorsWen Zheng, Jun Zhu, Yan Xie
JournalZhonghua zhong liu za zhi [Chinese journal of oncology] (Zhonghua Zhong Liu Za Zhi) Vol. 30 Issue 11 Pg. 875-6 (Nov 2008) ISSN: 0253-3766 [Print] China
PMID19173838 (Publication Type: Journal Article)
Chemical References
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin
  • Prednisone
Topics
  • Adolescent
  • Adult
  • Aged
  • Agranulocytosis (chemically induced)
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Cisplatin (administration & dosage, adverse effects)
  • Cyclophosphamide (administration & dosage, adverse effects)
  • Doxorubicin (administration & dosage, adverse effects)
  • Etoposide (administration & dosage, adverse effects)
  • Female
  • Follow-Up Studies
  • Humans
  • Lymphoma, T-Cell, Peripheral (drug therapy)
  • Male
  • Middle Aged
  • Nausea (chemically induced)
  • Prednisone (administration & dosage, adverse effects)
  • Remission Induction
  • Vincristine (administration & dosage, adverse effects)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: